scorecardresearchAlembic Pharmaceuticals Share Price Live NSE, BSE, Today - Alembic Pharmaceuticals

Alembic Pharmaceuticals

BSE: 533573 | NSE: APLLTD | ISIN: INE901L01018 | SECTOR: Biotechnology & Drugs

869.40 -20.70 (-2.33%)

18 Jun 2024, 09:24 (IST)
  • Open

    905.00
  • High

    917.50
  • Low

    865.00
  • Prev Close

    890.10
  • P/E

    -
  • Median P/E

    -
  • P/B

    -
  • Median P/B

    -
  • Market Cap

    170.89B
  • Volume

    14.39K
  • Vol. (20 day Avg.)

    0
  • PEG

    -
  • Div.Yield

    -
  • Bid

    868.00
  • Ask

    869.50

Company Description

  • Biotechnology & Drugs
  • BSE

    533573
  • NSE

    APLLTD
  • ISIN

    INE901L01018

Alembic Pharmaceuticals Limited is an India-based pharmaceutical company. The Company is involved in manufacturing and marketing India Formulations, International Generics, and Active Pharmaceutical Ingredients (API). It delivers a diverse and expanding range of generics across chronic segments. Its therapies include Dermatology, Anti-Infective, Cold & Cough, Gastrology, Cardiology, Anti-Diabetic, Ophthalmology, Nephro/Uro, Animal Health, Orthopaedic and Gynaecology. Products under International Generics are manufactured across its facilities in Panelav, Karkhadi and Jarod in Gujarat. It has research and development facilities in Vadodara (Gujarat), Hyderabad (Telangana), and New Jersey (United States). Its APIs are manufactured at its three plants in Panelav and Karkhadi in Gujarat. The manufacturing facility in Sikkim is for manufacturing its India Formulations. Its subsidiaries include Alembic Pharmaceuticals Inc., Alembic Global Holding SA and others.

Company Officers

  • Chirayu Amin

    Executive Chairman of the Board, Chief Executive Officer
  • Raj Baheti

    Chief Financial Officer, Director - Finance, Executive Director
  • Manisha Saraf

    Compliance Officer, Company Secretary
  • Pranav Amin

    Managing Director, Executive Director
  • Shaunak Amin

    Managing Director, Executive Director